Covid19
Conditions
Keywords
respiratory muscles, pulmonary functions
Brief summary
In literature, there is no data evaluating respiratory functions in volleyball players during Covid-19 pandemic. The aim of this study is to evaluate and compared pulmonary functions, respiratory muscle strength, body compositions and performance situations perceptions in female volleyball players with Covid-19 and non-Covid-19.
Interventions
OTHERRespiratory functions
Respiratory muscle strength, pulmonary functions and body composition were evaluated in volleyball players
Sponsors
Gazi University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
15 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* having passed at least 30 days after the Polymerase Chain Reaction (PCR) test turned negative * willing to participate in the study
Exclusion criteria
* having a history of chronic lung disease * unwilling to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Respiratory muscle strength | 10 minute | Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| FVC | 5 minute | Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FVC will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal |
| FEV1/FVC | 5 minute | Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1/FVC will be evaluated. |
| PEF | 5 minute | Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. PEF will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal. |
| FEF2575 | 5 minute | Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEF2575 will be evaluated. The percentage of predicted value \<50% will be expressed as abnormal. |
| Fat mass | 2 minute | Fat mass will be evaluated using TANITA bioelectrical impedance analysis. |
| FEV1 | 5 minute | Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respiratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal. |
| Fat-free mass | 2 minute | Fat-free mass will be evaluated using TANITA bioelectrical impedance analysis. |
| Body mass index | 2 minute | Body mass index will be evaluated using TANITA bioelectrical impedance analysis. |
| Predicted muscle mass | 2 minute | Predicted muscle mass will be evaluated using TANITA bioelectrical impedance analysis. |
| Symptom severity perceptions | 1 minute | Symptom severity perceptions will be evaluated Numeric Rating Scale.The severity of symptoms perceptions related to Covid are scored 0-10 point. Higher scores indicate higher severity of symptoms. |
| Performance situations perceptions | 1 minute | Performance situations perceptions will be evaluated Numeric Rating Scale. Performance situations perceptions of all players are also scored 0-10 point. Higher scores indicate greater performance. |
| Fat mass percent | 2 minute | Fat mass percent will be evaluated using TANITA bioelectrical impedance analysis. |
Countries
Turkey (Türkiye)
Outcome results
None listed